RE:Genetic sequencing4 Jul 2017 11:43
The last valuation I saw for Nanopore in May was £1.55B, so our 20% stake would be £310m or a third of our current mcap. My worry is how many tech companies, including Illumina, are working on a hand held sequencer. Nanopore will need another large injection of funding later this year that I doubt we can afford, they need to go public sooner rather than later.